Logo image of AEMD

AETHLON MEDICAL INC (AEMD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AEMD - US00808Y6041 - Common Stock

2.92 USD
+0.21 (+7.91%)
Last: 1/16/2026, 8:00:00 PM
2.9 USD
-0.02 (-0.68%)
After Hours: 1/16/2026, 8:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AEMD. AEMD was compared to 185 industry peers in the Health Care Equipment & Supplies industry. AEMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AEMD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • AEMD had negative earnings in the past year.
  • In the past year AEMD has reported a negative cash flow from operations.
  • In the past 5 years AEMD always reported negative net income.
  • In the past 5 years AEMD always reported negative operating cash flow.
AEMD Yearly Net Income VS EBIT VS OCF VS FCFAEMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • With a Return On Assets value of -153.74%, AEMD is not doing good in the industry: 87.57% of the companies in the same industry are doing better.
  • With a Return On Equity value of -195.94%, AEMD is not doing good in the industry: 72.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -153.74%
ROE -195.94%
ROIC N/A
ROA(3y)-131.15%
ROA(5y)-104.21%
ROE(3y)-181.8%
ROE(5y)-137.98%
ROIC(3y)N/A
ROIC(5y)N/A
AEMD Yearly ROA, ROE, ROICAEMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for AEMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AEMD Yearly Profit, Operating, Gross MarginsAEMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

6

2. Health

2.1 Basic Checks

  • The number of shares outstanding for AEMD has been increased compared to 1 year ago.
  • Compared to 5 years ago, AEMD has more shares outstanding
  • AEMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AEMD Yearly Shares OutstandingAEMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50K 100K 150K 200K 250K
AEMD Yearly Total Debt VS Total AssetsAEMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -34.36, we must say that AEMD is in the distress zone and has some risk of bankruptcy.
  • AEMD has a Altman-Z score of -34.36. This is amonst the worse of the industry: AEMD underperforms 90.27% of its industry peers.
  • There is no outstanding debt for AEMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -34.36
ROIC/WACCN/A
WACCN/A
AEMD Yearly LT Debt VS Equity VS FCFAEMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M 15M

2.3 Liquidity

  • A Current Ratio of 4.45 indicates that AEMD has no problem at all paying its short term obligations.
  • AEMD's Current ratio of 4.45 is fine compared to the rest of the industry. AEMD outperforms 75.14% of its industry peers.
  • AEMD has a Quick Ratio of 4.45. This indicates that AEMD is financially healthy and has no problem in meeting its short term obligations.
  • AEMD has a better Quick ratio (4.45) than 79.46% of its industry peers.
Industry RankSector Rank
Current Ratio 4.45
Quick Ratio 4.45
AEMD Yearly Current Assets VS Current LiabilitesAEMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

  • AEMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.64%, which is quite impressive.
EPS 1Y (TTM)54.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.63%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 14.58% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y91.47%
EPS Next 2Y40.36%
EPS Next 3Y25.2%
EPS Next 5Y14.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AEMD Yearly Revenue VS EstimatesAEMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2030 2031 2032 2033 10M 20M 30M 40M
AEMD Yearly EPS VS EstimatesAEMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5K -10K -15K -20K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AEMD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AEMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AEMD Price Earnings VS Forward Price EarningsAEMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AEMD Per share dataAEMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AEMD's earnings are expected to grow with 25.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.36%
EPS Next 3Y25.2%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for AEMD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

AETHLON MEDICAL INC

NASDAQ:AEMD (1/16/2026, 8:00:00 PM)

After market: 2.9 -0.02 (-0.68%)

2.92

+0.21 (+7.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)02-10
Inst Owners3.84%
Inst Owner Change0%
Ins Owners0.08%
Ins Owner Change-0.72%
Market Cap2.22M
Revenue(TTM)N/A
Net Income(TTM)-11.26M
Analysts45.71
Price Target12.62 (332.19%)
Short Float %1.69%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.5%
Min EPS beat(2)-0.09%
Max EPS beat(2)3.1%
EPS beat(4)2
Avg EPS beat(4)-157.59%
Min EPS beat(4)-673.64%
Max EPS beat(4)40.26%
EPS beat(8)3
Avg EPS beat(8)-77.31%
EPS beat(12)5
Avg EPS beat(12)-52.66%
EPS beat(16)7
Avg EPS beat(16)-43.84%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)309.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-467.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-438.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)-102.34
EYN/A
EPS(NY)-3.99
Fwd EYN/A
FCF(TTM)-9.29
FCFYN/A
OCF(TTM)-9.29
OCFYN/A
SpS0
BVpS7.56
TBVpS7.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -153.74%
ROE -195.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-131.15%
ROA(5y)-104.21%
ROE(3y)-181.8%
ROE(5y)-137.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.45
Quick Ratio 4.45
Altman-Z -34.36
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)153.85%
Cap/Depr(5y)180.64%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.63%
EPS Next Y91.47%
EPS Next 2Y40.36%
EPS Next 3Y25.2%
EPS Next 5Y14.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.06%
OCF growth 3YN/A
OCF growth 5YN/A

AETHLON MEDICAL INC / AEMD FAQ

Can you provide the ChartMill fundamental rating for AETHLON MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to AEMD.


Can you provide the valuation status for AETHLON MEDICAL INC?

ChartMill assigns a valuation rating of 1 / 10 to AETHLON MEDICAL INC (AEMD). This can be considered as Overvalued.


Can you provide the profitability details for AETHLON MEDICAL INC?

AETHLON MEDICAL INC (AEMD) has a profitability rating of 0 / 10.